Regs Must Resist Bank OTC Lobbying, Says NYSE
Regulatory supervisors in Europe and the U.S. should resist the extensive lobbying of banks when trying to overhaul the over-the-counter derivatives market, according to Fraser Cowie, executive director of global business development for NYSE Liffe.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts